|
US4609675A
(en)
|
1984-08-17 |
1986-09-02 |
The Upjohn Company |
Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
|
|
US4918098A
(en)
|
1986-03-12 |
1990-04-17 |
American Cyanamid Company |
Macrolide compounds
|
|
DK39892D0
(da)
|
1992-03-25 |
1992-03-25 |
Bernard Thorens |
Peptid
|
|
US5869602A
(en)
|
1995-03-17 |
1999-02-09 |
Novo Nordisk A/S |
Peptide derivatives
|
|
US5650386A
(en)
|
1995-03-31 |
1997-07-22 |
Emisphere Technologies, Inc. |
Compositions for oral delivery of active agents
|
|
US5866536A
(en)
|
1995-03-31 |
1999-02-02 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
SE9600070D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral pharmaceutical dosage forms
|
|
DE69737479T4
(de)
|
1996-08-30 |
2010-05-06 |
Novo Nordisk A/S |
Glp-1 derivate
|
|
US5773647A
(en)
|
1997-02-07 |
1998-06-30 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
WO1999043707A1
(en)
|
1998-02-27 |
1999-09-02 |
Novo Nordisk A/S |
N-terminally modified glp-1 derivatives
|
|
EP1056775B1
(en)
|
1998-02-27 |
2010-04-28 |
Novo Nordisk A/S |
Glp-1 derivatives of glp-1 and exendin with protracted profile of action
|
|
EP1061946B1
(en)
|
1998-02-27 |
2004-04-28 |
Novo Nordisk A/S |
Glp-1 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates
|
|
ATE466027T1
(de)
|
1998-02-27 |
2010-05-15 |
Novo Nordisk As |
Abkömmlinge von glp-1 analogen
|
|
SE9802080D0
(sv)
|
1998-06-11 |
1998-06-11 |
Hellstroem |
Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein
|
|
AU3357800A
(en)
|
1999-02-05 |
2000-08-25 |
Emisphere Technologies, Inc. |
Method of preparing alkylated salicylamides
|
|
WO2000048589A1
(en)
|
1999-02-22 |
2000-08-24 |
Emisphere Holdings, Inc. |
Solid oral dosage form containing heparin or a heparinoid in combination with a carrier
|
|
JP2002537321A
(ja)
|
1999-02-22 |
2002-11-05 |
エラン コーポレイション ピーエルスィー |
促進剤を含む固体経口剤形
|
|
US7658938B2
(en)
|
1999-02-22 |
2010-02-09 |
Merrion Reasearch III Limited |
Solid oral dosage form containing an enhancer
|
|
GB9923436D0
(en)
|
1999-10-04 |
1999-12-08 |
American Home Prod |
Pharmaceutical compositions
|
|
US6793934B1
(en)
|
1999-12-08 |
2004-09-21 |
Shire Laboratories, Inc. |
Solid oral dosage form
|
|
WO2001092206A1
(en)
|
2000-06-02 |
2001-12-06 |
Emisphere Technologies, Inc. |
Method of preparing salicylamides
|
|
US7049283B2
(en)
|
2000-12-06 |
2006-05-23 |
Novartis Ag |
Pharmaceutical compositions for the oral delivery of pharmacologically active agents
|
|
MXPA03008837A
(es)
|
2001-03-27 |
2004-05-05 |
Ranbaxy Lab Ltd |
Una composicion farmaceutica estable de pravastatina.
|
|
PL366728A1
(en)
|
2001-05-15 |
2005-02-07 |
Warner-Lambert Company Llc |
Compaction process for manufacture of sodium phenytoin dosage form
|
|
US20030068356A1
(en)
|
2001-07-10 |
2003-04-10 |
Pather S. Indiran |
Sequential drug delivery systems
|
|
AU2002352974A1
(en)
|
2001-11-29 |
2003-06-10 |
Emisphere Technologies, Inc. |
Formulations for oral administration of cromolyn sodium
|
|
WO2003063838A1
(en)
|
2002-02-01 |
2003-08-07 |
Pfizer Products Inc. |
Dry granulated formulations of azithromycin
|
|
JP4417113B2
(ja)
|
2002-02-20 |
2010-02-17 |
エミスフェアー・テクノロジーズ・インク |
Ｇｌｐ−１分子の投与方法
|
|
JP2004131398A
(ja)
|
2002-10-08 |
2004-04-30 |
Taihei Chemical Industrial Co Ltd |
錠剤用滑沢剤
|
|
CA2525168A1
(en)
|
2003-05-14 |
2004-12-02 |
Emisphere Technologies, Inc. |
Compositions for delivering peptide yy and pyy agonists
|
|
PL1651248T3
(pl)
|
2003-07-11 |
2010-02-26 |
Novartis Ag |
Doustnie dawkowana kompozycja farmaceutyczna zawierająca środek dostarczający w postaci mikronizowanej
|
|
JP4949838B2
(ja)
|
2003-09-19 |
2012-06-13 |
ノヴォ ノルディスク アー／エス |
新規ｇｌｐ−１誘導体
|
|
EP1704165B1
(en)
|
2003-12-18 |
2010-03-17 |
Novo Nordisk A/S |
Glp-1 compounds
|
|
AU2004298425A1
(en)
|
2003-12-18 |
2005-06-30 |
Novo Nordisk A/S |
Novel GLP-1 analogues linked to albumin-like agents
|
|
US20060286129A1
(en)
|
2003-12-19 |
2006-12-21 |
Emisphere Technologies, Inc. |
Oral GLP-1 formulations
|
|
WO2005099672A1
(en)
|
2004-04-13 |
2005-10-27 |
Ranbaxy Laboratories Limited |
A modified release pharmaceutical formulation comprising amoxicillin and clavulanate
|
|
JP2007536268A
(ja)
*
|
2004-05-06 |
2007-12-13 |
エミスフェアー・テクノロジーズ・インク |
固体剤形の湿性ヘパリン
|
|
CN102040536B
(zh)
|
2004-05-06 |
2013-06-19 |
爱密斯菲尔科技公司 |
N-[8-(2-羟基苯甲酰基)氨基]辛酸一钠的晶体的多晶
|
|
EP1756039B1
(en)
|
2004-05-14 |
2012-10-17 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
CN1767818A
(zh)
|
2004-05-31 |
2006-05-03 |
三亚药品株式会社 |
含β－内酰胺抗生素的分散片剂及其制备方法
|
|
CN101010339B
(zh)
|
2004-07-02 |
2011-11-09 |
布里斯托尔-迈尔斯斯奎布公司 |
人类胰高血糖素样肽-1调节剂及它们在治疗糖尿病及相关病况中的用途
|
|
ES2564167T3
(es)
|
2004-07-08 |
2016-03-18 |
Novo Nordisk A/S |
Conjugados de polipéptidos de acción prolongada que contienen una fracción tetrazol
|
|
EP1781257B1
(en)
|
2004-08-13 |
2018-12-19 |
Emisphere Technologies, Inc. |
Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
|
|
WO2006037811A2
(en)
|
2004-10-07 |
2006-04-13 |
Novo Nordisk A/S |
Protracted exendin-4 compounds
|
|
US7893017B2
(en)
|
2004-10-07 |
2011-02-22 |
Novo Nordisk A/S |
Protracted GLP-1 compounds
|
|
NZ555120A
(en)
|
2004-12-03 |
2009-11-27 |
Merck & Co Inc |
Pharmaceutical formulation of carboxamide HIV integrase inhibitors containing a release rate controlling composition
|
|
EP1843755B1
(en)
|
2005-02-01 |
2015-04-01 |
Emisphere Technologies, Inc. |
Gastric retention and controlled release delivery system
|
|
TWI362392B
(en)
|
2005-03-18 |
2012-04-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
KR20070120112A
(ko)
|
2005-03-18 |
2007-12-21 |
노보 노르디스크 에이/에스 |
연장형 ｇｌｐ-1 화합물
|
|
US20080260818A1
(en)
|
2005-03-28 |
2008-10-23 |
Dexcel Pharma Technologies Ltd. |
Controlled Absorption of Statins in the Intestine
|
|
US20070049557A1
(en)
|
2005-08-24 |
2007-03-01 |
Hashim Ahmed |
Solid pharmaceutical dosage forms comprising bisphosphonates and modified amino acid carriers
|
|
KR101432313B1
(ko)
|
2005-11-17 |
2014-08-20 |
노파르티스 아게 |
약제학적 조성물
|
|
BRPI0710503A2
(pt)
|
2006-04-07 |
2011-08-16 |
Merrion Res Iii Ltd |
uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
|
|
US8927015B2
(en)
|
2006-04-12 |
2015-01-06 |
Emisphere Technologies, Inc. |
Formulations for delivering insulin
|
|
JP2009539862A
(ja)
|
2006-06-09 |
2009-11-19 |
メリオン リサーチ Ｉｉｉ リミテッド |
強化剤を含む固体経口投与剤形
|
|
EP2040718B1
(en)
*
|
2006-06-28 |
2017-12-27 |
Emisphere Technologies, Inc. |
Gallium nitrate formulations
|
|
ES2296529B1
(es)
|
2006-08-07 |
2009-04-01 |
Laboratorios Farmaceuticos Rovi, S.A. |
Composicion farmaceutica con promotores de absorcion.
|
|
EP2057189B1
(en)
|
2006-08-25 |
2013-03-06 |
Novo Nordisk A/S |
Acylated exendin-4 compounds
|
|
JP5021033B2
(ja)
|
2006-09-07 |
2012-09-05 |
エフ．ホフマン−ラ ロシュ アーゲー |
Ｓｎａｃ（サルカプロザートナトリウム）の製造法
|
|
AR062925A1
(es)
|
2006-09-22 |
2008-12-17 |
Novartis Ag |
Metodo para fabricar tabletas que contienen agentes farmacologicamente activos
|
|
WO2008070547A1
(en)
|
2006-12-01 |
2008-06-12 |
Emisphere Technologies Inc. |
Improved acyclovir formulations
|
|
PL2131810T3
(pl)
|
2007-03-02 |
2011-09-30 |
Novartis Ag |
Podawanie doustne kalcytoniny
|
|
US20110183889A1
(en)
|
2007-08-29 |
2011-07-28 |
The Regents Of The University Of California |
Salicylanilide modified peptides for use as oral therapeutics
|
|
WO2009030771A1
(en)
|
2007-09-05 |
2009-03-12 |
Novo Nordisk A/S |
Peptides derivatized with a-b-c-d- and their therapeutical use
|
|
CN101842386A
(zh)
|
2007-09-05 |
2010-09-22 |
诺沃-诺迪斯克有限公司 |
截短的glp-1衍生物和它们的治疗用途
|
|
WO2009030738A1
(en)
|
2007-09-05 |
2009-03-12 |
Novo Nordisk A/S |
Glucagon-like peptide-1 derivatives and their pharmaceutical use
|
|
MX2010003979A
(es)
|
2007-10-16 |
2010-06-02 |
Biocon Ltd |
Composicion farmaceutica oralmente administrable y proceso para su preparacion.
|
|
MX2010004716A
(es)
|
2007-11-02 |
2010-12-17 |
Emisphere Tech Inc |
Metodo para tratar la deficiencia de vitamina b12.
|
|
US20090124639A1
(en)
*
|
2007-11-06 |
2009-05-14 |
Emisphere Technologies Inc. |
valacyclovir formulations
|
|
US20100317057A1
(en)
*
|
2007-12-28 |
2010-12-16 |
Novo Nordisk A/S |
Semi-recombinant preparation of glp-1 analogues
|
|
NZ591497A
(en)
*
|
2008-08-18 |
2012-11-30 |
Entera Bio Ltd |
A compositions comprising a protein, a protease inhibitor and N-(8-[2-hydroxybenzoyl]amino)caprylate (SNAC) or N-(10[2-hydroxybenzoyl]amino)decanoate (SNAD) for diabetes mellitus treatment
|
|
CN117547538A
(zh)
|
2009-02-13 |
2024-02-13 |
勃林格殷格翰国际有限公司 |
包含dpp-4抑制剂(利格列汀)任选地组合其它抗糖尿病药的抗糖尿病药物
|
|
AU2010339907A1
(en)
|
2009-12-16 |
2012-07-05 |
Nod Pharmaceuticals, Inc. |
Compositions and methods for oral drug delivery
|
|
US20110182985A1
(en)
|
2010-01-28 |
2011-07-28 |
Coughlan David C |
Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
|
|
WO2011109787A1
(en)
|
2010-03-05 |
2011-09-09 |
Conjuchem, Llc |
Methods of administering insulinotropic peptides
|
|
WO2011116139A2
(en)
|
2010-03-16 |
2011-09-22 |
Chiasma Inc. |
Improved pharmaceutical compositions and methods of delivery
|
|
AR081760A1
(es)
|
2010-04-07 |
2012-10-17 |
Vertex Pharma |
Una composicion farmaceutica para administracion oral que comprende acido 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-il)ciclopropancarboxamido)-3-metilpiridin-2-il)benzoico, un metodo para producir la misma, una tableta y una forma unitaria de dosificacion oral que la comprende y el uso de la misma para la fabricacion de un medicamento
|
|
CN107961377B
(zh)
|
2010-05-05 |
2022-11-22 |
勃林格殷格翰国际有限公司 |
组合疗法
|
|
DE202010015867U1
(de)
|
2010-11-25 |
2011-05-05 |
Buchhalter, Thomas |
Elektromechanische Halterung zur Aufnahme von Navigations- und Kommunikationsgeräte im KFZ
|
|
PT2651398T
(pt)
|
2010-12-16 |
2018-03-09 |
Novo Nordisk As |
Composições sólidas compreendendo um agonista de glp-1 e um sal de ácido n-(8-(2-hidroxibenzoil)amino) caprílico
|
|
EP4324475A1
(en)
|
2012-03-22 |
2024-02-21 |
Novo Nordisk A/S |
Compositions of glp-1 peptides and preparation thereof
|
|
EP2827845B1
(en)
|
2012-03-22 |
2018-12-26 |
Novo Nordisk A/S |
Compositions comprising a delivery agent and preparation thereof
|
|
CN104487056A
(zh)
|
2012-06-20 |
2015-04-01 |
诺和诺德A/S（股份有限公司） |
包含肽和递送剂的片剂制剂
|
|
PL2991671T3
(pl)
|
2013-05-02 |
2019-01-31 |
Novo Nordisk As |
Doustne dawkowanie związków glp-1
|